Abstract |
Forty-two missense, truncation, or splice-site mutations of the acetylcholine receptor (AChR) subunit genes have been reported to date in patients with congenital myasthenic syndromes. Here we report a homozygous mutation, epsilon-155G --> A, in the promoter region of the AChR epsilon subunit gene that converts the Ets-binding site of the promoter region from CGGAA to CAGAA. The asymptomatic parents and brother are heterozygous and an affected sister is homozygous for epislon-155G --> A. The Ets-binding site mediates synapse specific expression of the AChR epsilon subunit gene. An identical G-to-A mutation in the mouse Ets-binding site was previously shown to decrease the binding affinity of the Ets-binding site for the GA binding protein, a transactivating factor for the Ets-binding site, and to reduce the synapse specific expression of the epsilon subunit. The decreased synaptic expression of the epsilon subunit readily accounts for the congenital myasthenic phenotype.
|
Authors | K Ohno, B Anlar, A G Engel |
Journal | Neuromuscular disorders : NMD
(Neuromuscul Disord)
Vol. 9
Issue 3
Pg. 131-5
(May 1999)
ISSN: 0960-8966 [Print] England |
PMID | 10382905
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-ets
- Receptors, Cholinergic
- Transcription Factors
- DNA
|
Topics |
- Adolescent
- Base Sequence
- Binding Sites
(drug effects, genetics)
- Child
- DNA
(chemistry, genetics)
- DNA Mutational Analysis
- Family Health
- Female
- Gene Expression
- Humans
- Male
- Molecular Sequence Data
- Motor Endplate
(genetics)
- Mutation
- Myasthenia Gravis
(drug therapy, genetics)
- Pedigree
- Point Mutation
- Promoter Regions, Genetic
- Proto-Oncogene Proteins
(metabolism)
- Proto-Oncogene Proteins c-ets
- Receptors, Cholinergic
(genetics, metabolism)
- Sequence Homology, Nucleic Acid
- Syndrome
- Transcription Factors
(metabolism)
|